Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,141
Total Claims
$3.7M
Drug Cost
10,210
Beneficiaries
$359
Cost/Patient
Risk Score Breakdown 23/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-55%
Opioid rate vs peers
1.2% vs 2.6% avg
-66%
Cost per patient vs peers
$359 vs $1,068 avg
+649%
Brand preference vs peers
67.4% vs 9.0% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.2%
Opioid Rate
223
Opioid Claims
$14K
Opioid Cost
22.0%
Long-Acting Rate
Brand vs Generic
Brand: 12,835 claims · $3.5M
Generic: 6,217 claims · $149K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rsvpref3 Antigen/As01e/Pf | 4,253 | $1.3M |
| Varicella-Zoster Ge/As01b/Pf | 4,464 | $940K |
| Rsv Vacc, Pref A And Pref B/Pf | 1,966 | $637K |
| Apixaban | 80 | $80K |
| Emtricitabine/Tenofov Alafenam | 25 | $56K |
| Diphth,pertuss(Acell),tet Vac | 838 | $55K |
| Insulin Glargine,hum.Rec.Anlog | 29 | $44K |
| Dulaglutide | 29 | $37K |
| Dapagliflozin Propanediol | 21 | $29K |
| Semaglutide | 20 | $28K |
| Budesonide/Formoterol Fumarate | 25 | $28K |
| Hepatitis A And B Vaccine/Pf | 174 | $25K |
| Liraglutide | 14 | $14K |
| Insulin Detemir | 11 | $13K |
| Diph,pertuss(Acell),tet Vac/Pf | 155 | $11K |
Prescribing Profile
Patient Profile
74
Avg Age
57%
Female
1.05
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About